Stressing Out about Cancer Immunotherapy

Arbour, 2018, Impact of baseline steroids on efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 blockade in patients with non-small-cell lung cancer, J. Clin. Oncol., 36, 2872, 10.1200/JCO.2018.79.0006 Flint, 2016, Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity, Cell Metab., 24, 672, 10.1016/j.cmet.2016.10.010 Gopalakrishnan, 2018, The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy, Cancer Cell, 33, 570, 10.1016/j.ccell.2018.03.015 Kroemer, 2013, Immunogenic cell death in cancer therapy, Annu. Rev. Immunol., 31, 51, 10.1146/annurev-immunol-032712-100008 McEwen, 2007, Physiology and neurobiology of stress and adaptation: central role of the brain, Physiol. Rev., 87, 873, 10.1152/physrev.00041.2006 Moreno-Smith, 2010, Impact of stress on cancer metastasis, Future Oncol., 6, 1863, 10.2217/fon.10.142 Obradović, 2019, Glucocorticoids promote breast cancer metastasis, Nature, 567, 540, 10.1038/s41586-019-1019-4 Rhee, 2009, Principles and clinical implications of the brain-gut-enteric microbiota axis, Nat. Rev. Gastroenterol. Hepatol., 6, 306, 10.1038/nrgastro.2009.35 Sephton, 2000, Diurnal cortisol rhythm as a predictor of breast cancer survival, J. Natl. Cancer Inst., 92, 994, 10.1093/jnci/92.12.994 Yang, 2019, Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity, Nat. Med., 25, 1428, 10.1038/s41591-019-0566-4